Cargando…
A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia
SIMPLE SUMMARY: In spite of the recent expansion of the therapeutic landscape for acute myeloid leukemia (AML), resistance mechanisms and relapsed disease still pose a serious barrier to achieve curation for most patients. Considering the high inter- and intrapatient heterogeneity, disruptive therap...
Autores principales: | Carbó, José M., Cornet-Masana, Josep M., Cuesta-Casanovas, Laia, Delgado-Martínez, Jennifer, Banús-Mulet, Antònia, Clément-Demange, Lise, Serra, Carme, Catena, Juanlo, Llebaria, Amadeu, Esteve, Jordi, Risueño, Ruth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047683/ https://www.ncbi.nlm.nih.gov/pubmed/36980800 http://dx.doi.org/10.3390/cancers15061912 |
Ejemplares similares
-
Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells
por: Cornet-Masana, Josep M., et al.
Publicado: (2019) -
Histamine receptor 1 is expressed in leukaemic cells and affects differentiation sensitivity
por: Cornet‐Masana, Josep M., et al.
Publicado: (2020) -
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2023) -
Lysosome-mediated chemoresistance in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2022) -
Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016)